Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial. [PDF]
Naidoo A +15 more
europepmc +1 more source
Antiretroviral therapy persistence among treatment-experienced people with HIV and mental health disorders and/or substance use disorders in the USA (2017-2024): a retrospective cohort study. [PDF]
Mordi U +7 more
europepmc +1 more source
Turning back time: a comprehensive list of interventions that decrease next-generation epigenetic aging clocks in humans. [PDF]
Johnson AA, Sinclair DA.
europepmc +1 more source
Use of dual ART in individuals with different HBV serological patterns. [PDF]
Swaine T, Bhagani S.
europepmc +1 more source
Treatment-Emergent Bictegravir Resistance in a Treatment-Naive Individual With HIV Infection: A Case Report. [PDF]
Dubson I +5 more
europepmc +1 more source
Efficacy and safety of bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF) versus efavirenz, lamivudine, and tenofovir disoproxil fumarate (EFV+3TC + TDF) in late-presenting people with HIV rapid initial antiretroviral therapy. [PDF]
Li Q +6 more
europepmc +1 more source
Vaginal Microbiota and Cytokines Among Pregnant and Breastfeeding Women in Clinical Trials of the Dapivirine Vaginal Ring and Oral Tenofovir Disoproxil Fumarate/Emtricitabine. [PDF]
Petrina MAB +10 more
europepmc +1 more source
Bullous pemphigoid in a person living with human immunodeficiency virus: An association or coincidence. [PDF]
Kaushal I +5 more
europepmc +1 more source
Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1. [PDF]
Molina JM +7 more
europepmc +1 more source
Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083. [PDF]
Brown TT +12 more
europepmc +1 more source

